| scholarly article | Q13442814 |
| P2093 | author name string | Yuji Nakamura | |
| Schuichi Koizumi | |||
| Masahiko Matsumoto | |||
| Atsushi Sugiyama | |||
| Satomi Adachi-Akahane | |||
| Yoshitaka Mitsumori | |||
| Kiyotaka Hoshiai | |||
| Yukitoshi Nagayama | |||
| P2860 | cites work | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| Nippon Rinsho | Q26841908 | ||
| Milnacipran and selective serotonin reuptake inhibitors in major depression | Q28297103 | ||
| Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: potential utility of mexiletine for the treatment of drug-induced long QT syndrome | Q31440550 | ||
| Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. | Q34719967 | ||
| Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts | Q36801816 | ||
| Effects of the antihypoxic and neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording | Q40935881 | ||
| Pharmacokinetics of milnacipran in comparison with other antidepressants | Q41219213 | ||
| Electrophysiological effects of imipramine on bovine ventricular muscle and Purkinje fibres | Q42633084 | ||
| In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol | Q43624950 | ||
| Cardiac electrophysiologic and hemodynamic effects of sildenafil, a PDE5 inhibitor, in anesthetized dogs | Q43798819 | ||
| Effects of a typical I(Kr) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes | Q44015989 | ||
| Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients | Q44358151 | ||
| Comparison of sensitivity of surrogate markers of drug-induced torsades de pointes in canine hearts | Q45089174 | ||
| Further characterization of the effects of imipramine on plateau membrane currents in guinea-pig ventricular myocytes | Q46478727 | ||
| Electroencephalographic and cardiovascular effects of milnaciplan hydrochloride (TN-912), a novel antidepressant | Q46521868 | ||
| Sodium lactate reversal of electrophysiological effects of imipramine in guinea‐pig ventricular myocardium | Q46567854 | ||
| Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor | Q48026586 | ||
| Halothane sensitizes the canine heart to pharmacological IKr blockade. | Q51239691 | ||
| Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. | Q51450064 | ||
| Imipramine blocks rapidly activating and delays slowly activating K+ current activation in guinea pig ventricular myocytes. | Q54209806 | ||
| Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression | Q57480128 | ||
| Effect of imipramine on calcium and potassium currents in isolated bovine ventricular myocytes | Q61937398 | ||
| SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants | Q64116647 | ||
| The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations | Q66940497 | ||
| Comparative in vivo and in vitro study of the cardiac effects of midalcipran and imipramine | Q69698368 | ||
| Acute electrophysiological effects of intravenous milnacipran, a new antidepressant agent | Q72249703 | ||
| Electropharmacologic effects of a new phosphodiesterase III inhibitor, toborinone (OPC-18790), assessed in an in vivo canine model | Q74307434 | ||
| A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients | Q74837138 | ||
| Effects of gastrointestinal prokinetic agents, TKS159 and cisapride, on the in situ canine heart assessed by cardiohemodynamic and electrophysiological monitoring | Q77409999 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 275-282 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Cardiovascular Toxicology | Q2273398 |
| P1476 | title | In vivo canine model comparison of cardiovascular effects of antidepressants milnacipran and imipramine | |
| In Vivo Canine Model Comparison of Cardiovascular Effects of Antidepressants Milnacipran and Imipramine | |||
| P478 | volume | 10 |
| Q36548837 | Cardiotoxicity and serotonin syndrome complicating a milnacipran overdose |
| Q47762678 | Effects of psychopharmacological treatment with antidepressants on the vascular system |
| Q42702142 | Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K(+) Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model |
Search more.